ArticleJournal of robotic surgery2026
Technical feasibility and early outcomes of single-port robotic mediastinal mass resection through subxiphoid, intercostal, and subcostal approaches.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Robotic thoracic procedures can now be performed through a single incision using the da Vinci single-port (SP) system, which combines a flexible three-dimensional endoscope with articulating instruments in one platform. Although this platform has been increasingly used for anterior mediastinal surgery, particularly thymectomy, its role in other mediastinal compartments has not been well established. We reviewed our initial experience with SP robotic resection of mediastinal masses through three distinct access routes: subxiphoid, intercostal, and subcostal. We analyzed 64 consecutive patients who underwent SP robotic surgery for a mediastinal lesion between June 2021 and December 2025. For each patient, the entry route was planned after reviewing the lesion's compartment, dimensions, and the most suitable line of dissection. All 64 patients achieved complete resection without any case requiring conversion. Median console and total operative times were 89.5 and 125.5 min for thymectomy, and 51.0 and 84.5 min for mediastinal mass excision, respectively. No major intraoperative complications occurred. Postoperative chylothorax developed in two patients (3.1%), both of whom were managed conservatively. Thymoma (56.2%) and schwannoma (43.8%) represented the predominant histological diagnoses in the thymectomy and mass excision cohorts, respectively. Lesions involving the anterior, superior, and posterior mediastinum were all successfully resected. In this early series, SP robotic mediastinal mass resection was completed safely when access was tailored to tumor anatomy. Individualized access planning may extend the applicability of this platform beyond conventional anterior mediastinal procedures.
Indexed as
Identifiers
42766181What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.